Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole PK/Safety in Immunocompromised Adolescents
NCT00556998Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of voriconazole in fungal infection, sponsored by Pfizer. Primary endpoints: Area Under the Curve Over Dosing Interval at Steady State Following IV Administration, Peak Plasma Concentration at Steady State Following IV Administration and 4 more. Started Jun 2008; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00556998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556998.